Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149604 · ClinicalTrials.gov registry record · Phase 2
AFTER: Altering Fat Through Estrogen and Raloxifene
A Phase 2 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
NCT00149604 is a Phase 2 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 108 participants.
The verdict
NCT00149604, a Phase 2 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether estrogens specifically promote a reduction in fat from abdominal regions during weight loss and/or prevent the accumulation of abdominal fat during weight gain.
Interventions
- DRUG Raloxifene
- DRUG conjugated estrogens
- BEHAVIORAL exercise plus mild caloric restriction for weight loss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2000-03 |
| Est. Completion | 2006-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00149604
The ClinicalTrials.gov registry entry for NCT00149604 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Raloxifene is the first listed.
NCT00149604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00149604 about?
NCT00149604 is a clinical study titled "AFTER: Altering Fat Through Estrogen and Raloxifene". The purpose of this study is to determine whether estrogens specifically promote a reduction in fat from abdominal regions during weight loss and/or prevent the accumulation of abdominal fat during weight gain.
What is the current status of trial NCT00149604?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2000-03. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00149604?
The interventions under investigation include: Raloxifene (DRUG), conjugated estrogens (DRUG), exercise plus mild caloric restriction for weight loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT00149604?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.